De Filippi, R.; Marcacci, G.; Derenzini, E.; Musso, M.; Donnarumma, D.; Morelli, E.; Patti, C.; Maraglino, A.M.E.; Scalone, R.; Simeone, L.;
et al. Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study. Cancers 2022, 14, 5846.
https://doi.org/10.3390/cancers14235846
AMA Style
De Filippi R, Marcacci G, Derenzini E, Musso M, Donnarumma D, Morelli E, Patti C, Maraglino AME, Scalone R, Simeone L,
et al. Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study. Cancers. 2022; 14(23):5846.
https://doi.org/10.3390/cancers14235846
Chicago/Turabian Style
De Filippi, Rosaria, Gianpaolo Marcacci, Enrico Derenzini, Maurizio Musso, Daniela Donnarumma, Emanuela Morelli, Caterina Patti, Alessio Maria Edoardo Maraglino, Renato Scalone, Luigia Simeone,
and et al. 2022. "Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study" Cancers 14, no. 23: 5846.
https://doi.org/10.3390/cancers14235846
APA Style
De Filippi, R., Marcacci, G., Derenzini, E., Musso, M., Donnarumma, D., Morelli, E., Patti, C., Maraglino, A. M. E., Scalone, R., Simeone, L., Becchimanzi, C., Mele, S., Crisci, S., Morabito, F., & Pinto, A.
(2022). Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study. Cancers, 14(23), 5846.
https://doi.org/10.3390/cancers14235846
